June 29, 2025 - 02:52

President Trump has declared the suspension of trade negotiations with Canada, citing the country's proposed digital services tax on technology firms as an "egregious" attack on U.S. interests. This decision marks a significant escalation in the ongoing trade tensions that have characterized his second term in office.
In a bold move, Trump threatened to impose tariffs within seven days if Canada proceeds with the tax, which he argues unfairly targets American companies operating in the digital space. The proposed tax has been a contentious issue, with critics claiming it disproportionately affects U.S. tech giants.
In response, Canadian Prime Minister Carney reiterated the nation's commitment to protecting its economic interests and emphasized the importance of pursuing a fair and equitable trade relationship. As both countries brace for potential economic repercussions, the standoff highlights the complexities of international trade in an increasingly digital economy. The situation remains fluid, with stakeholders closely monitoring developments in the coming days.
October 28, 2026 - 23:36
CSX Works Through Tech Outage as Security Team Confirms No CyberattackCSX is working through a technology outage that began Tuesday, with the company`s security team confirming the disruption was not a cyberattack and that no data breach occurred, according to a...
October 28, 2026 - 06:35
The Human Side of Patient CRM Upgrades: Four Choices Tech Cannot SolveModernizing a patient relationship management system is often framed as a software problem, but the hardest parts are not technical. Jaymin Sutarwala of United Therapeutics argues that four key...
October 27, 2026 - 19:33
SPOOKY SPECTACULAR - GATEWAY HEADS-UP MAFIA 2026 GRAND FINALETwo days. More than 360 cars. Nearly $30,000 in payouts. One weekend that will not be forgotten anytime soon. Some races are good. Some are memorable. Then there are weekends that remind everyone...
October 27, 2026 - 00:50
Aptar Pharma Expands Pulmonary Delivery Capabilities with Pulmotree AcquisitionAptar Pharma, a division of AptarGroup Inc., has acquired Pulmotree, a life sciences company based in Munich, Germany. The move strengthens the company`s position in pulmonary drug delivery...